Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California. more
Time Frame | ICUI | Sector | S&P500 |
---|---|---|---|
1-Week Return | -1.84% | -3.39% | 0.2% |
1-Month Return | -7.54% | -1.92% | 2.72% |
3-Month Return | -10.85% | -10.54% | 7.31% |
6-Month Return | 32.62% | -4.47% | 10.44% |
1-Year Return | 60.18% | 4.06% | 27.53% |
3-Year Return | -31.86% | 0.94% | 30.88% |
5-Year Return | -14.85% | 36.67% | 89.21% |
10-Year Return | 89.18% | 102.87% | 199.95% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 1.27B | 1.27B | 1.32B | 2.28B | 2.26B | [{"date":"2019-12-31","value":55.54,"profit":true},{"date":"2020-12-31","value":55.75,"profit":true},{"date":"2021-12-31","value":57.73,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":99.08,"profit":true}] |
Cost of Revenue | 794.34M | 809.51M | 824.82M | 1.58B | 1.52B | [{"date":"2019-12-31","value":50.2,"profit":true},{"date":"2020-12-31","value":51.16,"profit":true},{"date":"2021-12-31","value":52.13,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":96.02,"profit":true}] |
Gross Profit | 471.86M | 461.50M | 491.49M | 697.76M | 739.87M | [{"date":"2019-12-31","value":63.78,"profit":true},{"date":"2020-12-31","value":62.38,"profit":true},{"date":"2021-12-31","value":66.43,"profit":true},{"date":"2022-12-31","value":94.31,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 37.27% | 36.31% | 37.34% | 30.60% | 32.75% | [{"date":"2019-12-31","value":99.81,"profit":true},{"date":"2020-12-31","value":97.24,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":81.96,"profit":true},{"date":"2023-12-31","value":87.71,"profit":true}] |
Operating Expenses | 331.33M | 325.93M | 350.21M | 701.33M | 717.05M | [{"date":"2019-12-31","value":46.21,"profit":true},{"date":"2020-12-31","value":45.45,"profit":true},{"date":"2021-12-31","value":48.84,"profit":true},{"date":"2022-12-31","value":97.81,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | 63.22M | 41.81M | 52.38M | (8.70M) | 22.82M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":66.13,"profit":true},{"date":"2021-12-31","value":82.86,"profit":true},{"date":"2022-12-31","value":-13.77,"profit":false},{"date":"2023-12-31","value":36.1,"profit":true}] |
Total Non-Operating Income/Expense | 50.94M | (2.42M) | (917.00K) | (137.89M) | (196.34M) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-4.75,"profit":false},{"date":"2021-12-31","value":-1.8,"profit":false},{"date":"2022-12-31","value":-270.69,"profit":false},{"date":"2023-12-31","value":-385.45,"profit":false}] |
Pre-Tax Income | 114.71M | 97.49M | 123.19M | (114.41M) | (78.30M) | [{"date":"2019-12-31","value":93.12,"profit":true},{"date":"2020-12-31","value":79.14,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-92.88,"profit":false},{"date":"2023-12-31","value":-63.56,"profit":false}] |
Income Taxes | 13.67M | 10.62M | 20.05M | (40.12M) | (48.64M) | [{"date":"2019-12-31","value":68.19,"profit":true},{"date":"2020-12-31","value":52.98,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-200.1,"profit":false},{"date":"2023-12-31","value":-242.6,"profit":false}] |
Income After Taxes | 101.03M | 86.87M | 103.14M | (74.29M) | (29.66M) | [{"date":"2019-12-31","value":97.96,"profit":true},{"date":"2020-12-31","value":84.23,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-72.03,"profit":false},{"date":"2023-12-31","value":-28.75,"profit":false}] |
Income From Continuous Operations | 101.03M | 86.87M | 103.14M | (74.29M) | (29.66M) | [{"date":"2019-12-31","value":97.96,"profit":true},{"date":"2020-12-31","value":84.23,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-72.03,"profit":false},{"date":"2023-12-31","value":-28.75,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 101.03M | 86.87M | 103.14M | (74.29M) | (29.66M) | [{"date":"2019-12-31","value":97.96,"profit":true},{"date":"2020-12-31","value":84.23,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-72.03,"profit":false},{"date":"2023-12-31","value":-28.75,"profit":false}] |
EPS (Diluted) | 8.16 | 7.13 | 7.39 | 6.54 | 6.76 | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":87.38,"profit":true},{"date":"2021-12-31","value":90.56,"profit":true},{"date":"2022-12-31","value":80.15,"profit":true},{"date":"2023-12-31","value":82.84,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
ICUI | |
---|---|
Cash Ratio | 0.57 |
Current Ratio | 2.29 |
Quick Ratio | 1.03 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
ICUI | |
---|---|
ROA (LTM) | 0.66% |
ROE (LTM) | -5.35% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
ICUI | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.52 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.48 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
ICUI | |
---|---|
Trailing PE | NM |
Forward PE | 21.05 |
P/S (TTM) | 1.64 |
P/B | 1.88 |
Price/FCF | 179 |
EV/R | 2.22 |
EV/Ebitda | 23.63 |
PEG | 1.70 |
ICU Medical Inc (ICUI) share price today is $157.274
Yes, Indians can buy shares of ICU Medical Inc (ICUI) on Vested. To buy ICU Medical Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ICUI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of ICU Medical Inc (ICUI) via the Vested app. You can start investing in ICU Medical Inc (ICUI) with a minimum investment of $1.
You can invest in shares of ICU Medical Inc (ICUI) via Vested in three simple steps:
The 52-week high price of ICU Medical Inc (ICUI) is $196.26. The 52-week low price of ICU Medical Inc (ICUI) is $86.8.
The price-to-earnings (P/E) ratio of ICU Medical Inc (ICUI) is
The price-to-book (P/B) ratio of ICU Medical Inc (ICUI) is 1.88
The dividend yield of ICU Medical Inc (ICUI) is 0.00%
The market capitalization of ICU Medical Inc (ICUI) is $3.85B
The stock symbol (or ticker) of ICU Medical Inc is ICUI